• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病治疗流行病学研究的文献计量分析

Bibliometric Analysis of the Epidemiological Research on Alzheimer's Disease Treatment.

作者信息

Chowdhury Anayah, Bhasin Garv, Ganti Latha

机构信息

Research, Canterbury School, Fort Myers, USA.

Biology, Brown University, Providence, USA.

出版信息

Cureus. 2025 Jul 7;17(7):e87484. doi: 10.7759/cureus.87484. eCollection 2025 Jul.

DOI:10.7759/cureus.87484
PMID:40786362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12331537/
Abstract

Alzheimer's disease presents a complex global health issue. It is characterized by a decline in cognitive function, starting with memory impairment, and extending to impact reasoning, language abilities, and spatial awareness. Despite decades of research, Alzheimer's disease remains a global challenge lacking long-term treatments. Institutions like the Karolinska Institutet, Columbia University, the University of California San Francisco (UCSF), and the University of Pittsburgh contribute significantly to Alzheimer's research, with a growth in publications in 2022 post-COVID-19. While current treatments offer symptomatic relief, there's a need for disease-modifying therapies targeting its mechanisms. This analysis aims to provide a comprehensive overview of the available research and medical literature on Alzheimer's disease by employing bibliometric methods to identify publication trends, leading research institutions, and the evolving focus from symptomatic treatments to disease-modifying therapies. This paper seeks to analyze the research papers on Alzheimer's disease and catalog the metadata associated with each paper.

摘要

阿尔茨海默病是一个复杂的全球健康问题。其特征是认知功能下降,始于记忆障碍,并扩展到影响推理、语言能力和空间意识。尽管经过了数十年的研究,但阿尔茨海默病仍然是一个缺乏长期治疗方法的全球性挑战。卡罗林斯卡学院、哥伦比亚大学、加利福尼亚大学旧金山分校(UCSF)和匹兹堡大学等机构对阿尔茨海默病研究做出了重大贡献,2022年新冠疫情后相关出版物有所增加。虽然目前的治疗方法能缓解症状,但仍需要针对其发病机制的疾病修饰疗法。本分析旨在通过文献计量方法全面概述有关阿尔茨海默病的现有研究和医学文献,以确定出版趋势、主要研究机构,以及从对症治疗到疾病修饰疗法的研究重点演变。本文旨在分析关于阿尔茨海默病的研究论文,并编目与每篇论文相关的元数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/17dba51a8015/cureus-0017-00000087484-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/7d8fd502c6b1/cureus-0017-00000087484-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/8202edded089/cureus-0017-00000087484-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/7e537d983087/cureus-0017-00000087484-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/9e9febbc6b10/cureus-0017-00000087484-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/17dba51a8015/cureus-0017-00000087484-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/7d8fd502c6b1/cureus-0017-00000087484-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/8202edded089/cureus-0017-00000087484-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/7e537d983087/cureus-0017-00000087484-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/9e9febbc6b10/cureus-0017-00000087484-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f6/12331537/17dba51a8015/cureus-0017-00000087484-i05.jpg

相似文献

1
Bibliometric Analysis of the Epidemiological Research on Alzheimer's Disease Treatment.阿尔茨海默病治疗流行病学研究的文献计量分析
Cureus. 2025 Jul 7;17(7):e87484. doi: 10.7759/cureus.87484. eCollection 2025 Jul.
2
A bibliometric analysis of the current research status and hotspots regarding Aducanumab treatment for Alzheimer's disease.关于阿杜卡奴单抗治疗阿尔茨海默病的当前研究现状和热点的文献计量分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 10. doi: 10.1007/s00210-025-04448-6.
3
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
4
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
5
Tracing inflammasomes in Alzheimer's: insights from bibliometric analysis.追踪阿尔茨海默病中的炎性小体:文献计量分析的见解
Front Neurol. 2025 Jun 5;16:1540083. doi: 10.3389/fneur.2025.1540083. eCollection 2025.
6
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
7
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
8
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.
9
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2002(3):CD000147. doi: 10.1002/14651858.CD000147.
10
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.

本文引用的文献

1
2024 Alzheimer's disease facts and figures.2024 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.
2
The several ways to authentically cure Alzheimer's dementia.真正治愈阿尔茨海默病性痴呆的几种方法。
Ageing Res Rev. 2023 Dec;92:102093. doi: 10.1016/j.arr.2023.102093. Epub 2023 Oct 20.
3
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
4
Alzheimer's Disease: Treatment Strategies and Their Limitations.阿尔茨海默病:治疗策略及其局限性。
Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954.
5
Comprehensive Review on Alzheimer's Disease: Causes and Treatment.阿尔茨海默病的综合综述:病因与治疗。
Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789.
6
The global prevalence of dementia: a systematic review and metaanalysis.全球痴呆症患病率:系统评价和荟萃分析。
Alzheimers Dement. 2013 Jan;9(1):63-75.e2. doi: 10.1016/j.jalz.2012.11.007.
7
Epidemiology of Alzheimer disease.阿尔茨海默病的流行病学。
Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a006239. doi: 10.1101/cshperspect.a006239.
8
Prevalence of dementia in the United States: the aging, demographics, and memory study.美国痴呆症患病率:老龄化、人口统计学与记忆研究
Neuroepidemiology. 2007;29(1-2):125-32. doi: 10.1159/000109998. Epub 2007 Oct 29.
9
The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias.阿尔茨海默病基础:阿尔茨海默病及相关痴呆症中的认知变化及其管理
Int Psychogeriatr. 2002;14 Suppl 1:51-75. doi: 10.1017/s1041610203008664.
10
What is cognitive reserve? Theory and research application of the reserve concept.什么是认知储备?储备概念的理论与研究应用。
J Int Neuropsychol Soc. 2002 Mar;8(3):448-60.